Ypsomed Holding AG's revenue for the
six
months ended in Sep. 2023 was CHF255.4 Mil.
Its revenue for the trailing twelve months (TTM) ended in Sep. 2023 was CHF508.6 Mil.
Ypsomed Holding AG's Revenue per Share for the
six
months ended in Sep. 2023 was CHF18.71.
Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was CHF37.31.
Warning Sign:
Ypsomed Holding AG revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Ypsomed Holding AG was -0.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 5.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 0.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 6.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Ypsomed Holding AG's highest 3-Year average Revenue per Share Growth Rate was 34.00% per year. The lowest was -91.60% per year. And the median was 1.80% per year.
Ypsomed Holding AG Revenue Historical Data
The historical data trend for Ypsomed Holding AG's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ypsomed Holding AG's Revenue
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Revenue distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's Revenue falls into.
Ypsomed Holding AG Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF508.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ypsomed Holding AG (XSWX:YPSN) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Ypsomed Holding AG Revenue Related Terms
Thank you for viewing the detailed overview of Ypsomed Holding AG's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Ypsomed Holding AG (XSWX:YPSN) Business Description
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:YPSN has been successfully added to your 